Supernus Pharmaceuticals, Inc. (SUPN)
40.70
-1.37
(-3.26%)
USD |
NASDAQ |
Oct 23, 16:00
40.68
-0.02
(-0.06%)
Pre-Market: 20:00
Supernus Pharmaceuticals Market Cap : 2.367B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.367B |
| October 22, 2026 | 2.447B |
| October 21, 2026 | 2.397B |
| October 20, 2026 | 2.398B |
| October 19, 2026 | 2.317B |
| October 16, 2026 | 2.203B |
| October 15, 2026 | 2.302B |
| October 14, 2026 | 2.337B |
| October 13, 2026 | 2.443B |
| October 12, 2026 | 2.490B |
| October 09, 2026 | 2.482B |
| October 08, 2026 | 2.451B |
| October 07, 2026 | 2.504B |
| October 06, 2026 | 2.491B |
| October 05, 2026 | 2.487B |
| October 02, 2026 | 2.465B |
| October 01, 2026 | 2.453B |
| September 30, 2026 | 2.503B |
| September 29, 2026 | 2.557B |
| September 28, 2026 | 2.594B |
| September 25, 2026 | 2.481B |
| September 24, 2026 | 2.518B |
| September 23, 2026 | 2.524B |
| September 22, 2026 | 2.545B |
| September 21, 2026 | 2.488B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.443B |
| September 17, 2026 | 2.496B |
| September 16, 2026 | 2.407B |
| September 15, 2026 | 2.401B |
| September 14, 2026 | 2.413B |
| September 11, 2026 | 2.422B |
| September 10, 2026 | 2.425B |
| September 09, 2026 | 2.447B |
| September 08, 2026 | 2.468B |
| September 04, 2026 | 2.532B |
| September 03, 2026 | 2.557B |
| September 02, 2026 | 2.561B |
| September 01, 2026 | 2.544B |
| August 31, 2026 | 2.571B |
| August 28, 2026 | 2.544B |
| August 27, 2026 | 2.570B |
| August 26, 2026 | 2.610B |
| August 25, 2026 | 2.638B |
| August 24, 2026 | 2.624B |
| August 21, 2026 | 2.667B |
| August 20, 2026 | 2.760B |
| August 19, 2026 | 2.823B |
| August 18, 2026 | 2.852B |
| August 17, 2026 | 2.808B |
| August 14, 2026 | 2.808B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Indivior Pharmaceuticals, Inc. | 4.067B |
| Prestige Consumer Healthcare, Inc. | 2.264B |
| Amphastar Pharmaceuticals, Inc. | 1.069B |
| Bristol Myers Squibb Co. | 125.60B |
| Liquidia Corp. | 3.800B |
Market Cap Related Metrics
| PS Ratio | 2.813 |
| Price to Book Value | 2.296 |
| Price to Free Cash Flow | 124.36 |
| Price | 40.70 |
| Earnings Yield | -4.70% |